Latest Steps In FDA Homeopathy Policy Overhaul Prompt Trade Group Questions
A revised draft introduces list of risk-based enforcement priorities but doesn't necessarily tighten FDA oversight of homeopathics manufacturing and marketing, say CHPA and AIH.
